Goldman Sachs has issued a report that Intuitive Surgical ISRG has been removed from Americas Sell List and upgraded to a Neutral Rating.
Goldman Sachs writes, "Following strong 2Q2011 results, evidence has emerged that the company has more potential longterm growth drivers (namely new procedure categories and the ability to reach a broader hospital population) than we had factored into our thesis."
ISRG has a $370 Price Target and closed yesterday at $374.90 a share.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in